Assessment of Liver FIBROsis by Real-time Tissue ELASTography in Chronic Liver Disease

Assessment of Liver FIBROsis by Real-time Tissue ELASTography in Chronic Liver Disease - FIBROELAST Study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000004431

Enrollment

500

Registered

2010-10-21

Start date

2010-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Hepatitis B Chronic Hepatitis C

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: * Male or female and at least 20 years of age * Chronic hepatitis B or Chronic hepatitis C * Subject is willing to fast for 8 hours prior to each study visit

Exclusion criteria

Exclusion criteria: * History of alcohol abuse (alcohol intake > 20g/day) * Evidence or history of chronic hepatitis not caused by HBV or HCV * During 6 months before registration to this trial has completed, nucleic acid analogue preparations or interferon therapy was performed. * Pregnant or lactating patients * Contraindications of liver biopsy or liver resection

Design outcomes

Primary

Measure	Time frame
Correlative evaluation with liver fibrosis by Real-time Tissue Elastography and histological diagnosis.	—

Secondary

Measure	Time frame
Correlative evaluation with liver fibrosis by Real-time Tissue Elastography and serum maker. Correlative evaluation with liver fibrosis by Real-time Tissue Elastography and FibroScan.	—

Countries

Japan

Contacts

Public ContactNorihisa Yada

Kinki University Faculty of Medicine Department of Gastroenterology and Hepatology

yada@med.kindai.ac.jp072-366-0221

Outcome results